311 related articles for article (PubMed ID: 30827006)
1. Ulcerative Colitis: Shifting Sands.
D'Haens GRAM; Lindsay JO; Panaccione R; Schreiber S
Drugs R D; 2019 Jun; 19(2):227-234. PubMed ID: 30827006
[TBL] [Abstract][Full Text] [Related]
2. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitis.
Ochsenkühn T; Tillack C; Szokodi D; Janelidze S; Schnitzler F
United European Gastroenterol J; 2020 Feb; 8(1):91-98. PubMed ID: 32213052
[TBL] [Abstract][Full Text] [Related]
4. Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus.
Bressler B; Marshall JK; Bernstein CN; Bitton A; Jones J; Leontiadis GI; Panaccione R; Steinhart AH; Tse F; Feagan B;
Gastroenterology; 2015 May; 148(5):1035-1058.e3. PubMed ID: 25747596
[TBL] [Abstract][Full Text] [Related]
5. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
[TBL] [Abstract][Full Text] [Related]
6. AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis.
Singh S; Allegretti JR; Siddique SM; Terdiman JP
Gastroenterology; 2020 Apr; 158(5):1465-1496.e17. PubMed ID: 31945351
[TBL] [Abstract][Full Text] [Related]
7. [Medical therapy of inflammatory bowel diseases: ulcerative colitis].
Lakatos L; Lakatos PL
Orv Hetil; 2007 Jun; 148(25):1163-70. PubMed ID: 17573252
[TBL] [Abstract][Full Text] [Related]
8. Ulcerative Colitis: Update on Medical Management.
Iskandar HN; Dhere T; Farraye FA
Curr Gastroenterol Rep; 2015 Nov; 17(11):44. PubMed ID: 26386686
[TBL] [Abstract][Full Text] [Related]
9. Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn's disease and ulcerative colitis - experiences from a single center.
Farkas K; Rutka M; Ferenci T; Nagy F; Bálint A; Bor R; Milassin Á; Fábián A; Szántó K; Végh Z; Kürti Z; Lakatos PL; Szepes Z; Molnár T
Expert Opin Biol Ther; 2017 Nov; 17(11):1325-1332. PubMed ID: 28819991
[TBL] [Abstract][Full Text] [Related]
10. An approach to acute severe ulcerative colitis.
Sedano R; Quera R; Simian D; Yarur AJ
Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):943-955. PubMed ID: 31648574
[No Abstract] [Full Text] [Related]
11. Self-reported frequency and severity of disease flares, disease perception, and flare treatments in patients with ulcerative colitis: results of a national internet-based survey.
Bolge SC; Waters H; Piech CT
Clin Ther; 2010 Feb; 32(2):238-45. PubMed ID: 20206781
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission.
Lichtenstein GR; Gordon GL; Zakko S; Murthy U; Sedghi S; Pruitt R; Barrett AC; Bortey E; Paterson C; Forbes WP
Dig Dis Sci; 2016 Jan; 61(1):221-9. PubMed ID: 26563167
[TBL] [Abstract][Full Text] [Related]
14. High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO)
Ylisaukko-Oja T; Aaltonen J; Nuutinen H; Blomster T; Jussila A; Pajala M; Salminen K; Moilanen V; Hakala K; Kellokumpu M; Toljamo K; Rautiainen H; Kuisma J; Peräaho M; Molander P; Silvennoinen J; Liukkonen V; Henricson H; Tillonen J; Esterinen M; Nielsen C; Hirsi E; Lääne M; Suhonen UM; Vihriälä I; Mäkelä P; Puhto M; Punkkinen J; Sulonen H; Herrala S; Jokelainen J; Tamminen K; Sipponen T
Scand J Gastroenterol; 2018 Feb; 53(2):158-167. PubMed ID: 29258369
[TBL] [Abstract][Full Text] [Related]
15. Treatment Patterns and Sequencing in Patients With Inflammatory Bowel Disease.
Brady JE; Stott-Miller M; Mu G; Perera S
Clin Ther; 2018 Sep; 40(9):1509-1521.e5. PubMed ID: 30126706
[TBL] [Abstract][Full Text] [Related]
16. Ulcerative colitis in infancy.
Rukunuzzaman M; Karim AS
Saudi J Gastroenterol; 2011; 17(6):414-7. PubMed ID: 22064342
[TBL] [Abstract][Full Text] [Related]
17. Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study.
Richter JM; Kushkuley S; Barrett JA; Oster G
Aliment Pharmacol Ther; 2012 Aug; 36(3):248-56. PubMed ID: 22690748
[TBL] [Abstract][Full Text] [Related]
18. Influence of Corticosteroid Use on Short- and Long-Term Outcomes of Biologic Therapy for Inflammatory Bowel Diseases.
Sieber A; Aberra FN; Bonhomme B; McKeever L; Lewis JD
Dig Dis Sci; 2022 Nov; 67(11):5168-5176. PubMed ID: 35094254
[TBL] [Abstract][Full Text] [Related]
19. Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.
Feuerstein JD; Isaacs KL; Schneider Y; Siddique SM; Falck-Ytter Y; Singh S;
Gastroenterology; 2020 Apr; 158(5):1464. PubMed ID: 32169295
[No Abstract] [Full Text] [Related]
20. Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials.
Regueiro M; Loftus EV; Steinhart AH; Cohen RD
Inflamm Bowel Dis; 2006 Oct; 12(10):979-94. PubMed ID: 17012969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
